Used in pharmaceutical research as a potential antipsychotic agent, this compound acts as a dopamine D4 receptor antagonist. It has been investigated for its role in treating central nervous system disorders, particularly schizophrenia, due to its selectivity for D4 receptors which are implicated in cognitive and emotional regulation. Its structure allows for blood-brain barrier penetration, making it suitable for central targets. Additionally, it serves as a lead compound in optimizing drug candidates with improved efficacy and reduced side effects compared to typical antipsychotics.